Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: Q4Q0B3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 102 | 104 | PF00675 | 0.554 |
CLV_NRD_NRD_1 | 169 | 171 | PF00675 | 0.501 |
CLV_PCSK_SKI1_1 | 175 | 179 | PF00082 | 0.628 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.445 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.447 |
DOC_MAPK_gen_1 | 90 | 98 | PF00069 | 0.431 |
DOC_MAPK_HePTP_8 | 123 | 135 | PF00069 | 0.322 |
DOC_MAPK_MEF2A_6 | 126 | 135 | PF00069 | 0.333 |
DOC_PP4_FxxP_1 | 154 | 157 | PF00568 | 0.467 |
DOC_PP4_FxxP_1 | 76 | 79 | PF00568 | 0.507 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.622 |
DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.526 |
LIG_14-3-3_CanoR_1 | 103 | 109 | PF00244 | 0.472 |
LIG_14-3-3_CanoR_1 | 122 | 126 | PF00244 | 0.467 |
LIG_14-3-3_CanoR_1 | 184 | 192 | PF00244 | 0.455 |
LIG_14-3-3_CanoR_1 | 23 | 27 | PF00244 | 0.467 |
LIG_14-3-3_CanoR_1 | 71 | 77 | PF00244 | 0.382 |
LIG_Actin_WH2_2 | 55 | 73 | PF00022 | 0.536 |
LIG_APCC_ABBA_1 | 56 | 61 | PF00400 | 0.511 |
LIG_APCC_ABBAyCdc20_2 | 55 | 61 | PF00400 | 0.497 |
LIG_BH_BH3_1 | 35 | 51 | PF00452 | 0.542 |
LIG_BRCT_BRCA1_1 | 182 | 186 | PF00533 | 0.517 |
LIG_deltaCOP1_diTrp_1 | 172 | 178 | PF00928 | 0.498 |
LIG_Dynein_DLC8_1 | 136 | 142 | PF01221 | 0.573 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.479 |
LIG_FHA_1 | 140 | 146 | PF00498 | 0.511 |
LIG_LIR_Apic_2 | 151 | 157 | PF02991 | 0.484 |
LIG_LIR_Apic_2 | 75 | 79 | PF02991 | 0.510 |
LIG_LIR_Gen_1 | 94 | 99 | PF02991 | 0.377 |
LIG_LIR_LC3C_4 | 130 | 135 | PF02991 | 0.324 |
LIG_LIR_Nem_3 | 94 | 98 | PF02991 | 0.375 |
LIG_OCRL_FandH_1 | 88 | 100 | PF00620 | 0.474 |
LIG_SH2_STAP1 | 74 | 78 | PF00017 | 0.495 |
LIG_SH2_STAT3 | 106 | 109 | PF00017 | 0.373 |
LIG_SH2_STAT5 | 106 | 109 | PF00017 | 0.373 |
LIG_SH2_STAT5 | 74 | 77 | PF00017 | 0.444 |
LIG_UBA3_1 | 165 | 171 | PF00899 | 0.493 |
LIG_WRC_WIRS_1 | 73 | 78 | PF05994 | 0.367 |
MOD_Cter_Amidation | 101 | 104 | PF01082 | 0.556 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.565 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.535 |
MOD_GSK3_1 | 39 | 46 | PF00069 | 0.435 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.542 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.466 |
MOD_PIKK_1 | 137 | 143 | PF00454 | 0.593 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.440 |
MOD_PKA_2 | 137 | 143 | PF00069 | 0.504 |
MOD_PKA_2 | 22 | 28 | PF00069 | 0.441 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.389 |
MOD_SUMO_rev_2 | 47 | 57 | PF00179 | 0.605 |
TRG_ER_diArg_1 | 189 | 192 | PF00400 | 0.472 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HYZ7 | Leptomonas seymouri | 87% | 100% |
A0A0S4IQL1 | Bodo saltans | 63% | 100% |
A0A1X0NLH3 | Trypanosomatidae | 70% | 100% |
A0A3R7MH65 | Trypanosoma rangeli | 69% | 100% |
A0A3S7XC64 | Leishmania donovani | 97% | 100% |
A4HQG5 | Leishmania braziliensis | 92% | 100% |
A4ICA1 | Leishmania infantum | 97% | 100% |
D0A3L6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 68% | 100% |
E9AU81 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |